Kirchhofer; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kirchhofer; Daniel.The latest application filed is for "compositions and methods for treating cardiovascular disease".

Company Profile

4.12.16

Kirchhofer; Daniel - Los Altos CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for treating cardiovascular disease Grant 11,034,725 - Beresini , et al. June 15, 2	2021-06-15
Compositions and methods for treating cardiovascular disease Grant 10,787,484 - Beresini , et al. September 29, 2	2020-09-29
Compositions And Methods For Treating Cardiovascular Disease App 20200283478 - Beresini; Maureen ; et al.	2020-09-10
Compositions And Methods For Treating Cardiovascular Disease App 20190177366 - Beresini; Maureen ; et al.	2019-06-13
ANTI-HtrA1 ANTIBODIES AND METHODS OF USE App 20190016826 - Wu; Yan ; et al.	2019-01-17
ANTI-HtrA1 ANTIBODIES AND METHODS OF USE App 20170342163 - WU; Yan ; et al.	2017-11-30
Anti-HtrA1 antibodies and methods of use Grant 9,738,727 - Wu , et al. August 22, 2	2017-08-22
Modulators of hepatocyte growth factor activator Grant 8,759,491 - Ganesan , et al. June 24, 2	2014-06-24
Methods and compositions for modulating hepsin activation of macrophage-stimulating protein Grant 8,697,386 - Ganesan , et al. April 15, 2	2014-04-15
ANTI-HtrA1 ANTIBODIES AND METHODS OF USE App 20130129743 - WU; Yan ; et al.	2013-05-23
Anti-hepsin antibodies and methods using same Grant 8,435,511 - Ganesan , et al. May 7, 2	2013-05-07
Methods And Compositions For Modulating Hepsin Activation Of Macrophage-stimulating Protein App 20120282271 - Ganesan; Rajkumar ; et al.	2012-11-08
Anti-pcsk9 Antibodies And Methods Of Use App 20120195910 - WU; YAN ; et al.	2012-08-02
Anti-hepsin Antibodies And Methods Using Same App 20110262452 - Ganesan; Rajkumar ; et al.	2011-10-27
Methods and compositions for modulating hepatocyte growth factor activator App 20110206704 - Ganesan; Rajkumar ; et al.	2011-08-25
Modulators Of Hepatocyte Growth Factor Activator App 20110091477 - Ganesan; Rajkumar ; et al.	2011-04-21
Treatment For Antiphospholipid-syndrome-related Pregnancy Complications App 20090214563 - Kirchhofer; Daniel ; et al.	2009-08-27
Novel Gene Disruptions, Composition and Methods Relating Thereto App 20080305106 - Brennan; Jane ; et al.	2008-12-11
Methods of treating coagulapathic or thrombotic disorders Grant 7,354,585 - Adams , et al. April 8, 2	2008-04-08
Human anti-factor IX/IXa antibodies App 20060193851 - Adams; Camellia W. ; et al.	2006-08-31
Human anti-factor IX/IXa antibodies Grant 7,049,411 - Adams , et al. May 23, 2	2006-05-23
Human Anti-factor Ix/ixa Antibodies App 20060088534 - Adams; Camellia W. ; et al.	2006-04-27
Human anti-factor IX/IXa antibodies Grant 6,624,295 - Adams , et al. September 23, 2	2003-09-23
Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents App 20030143225 - Refino, Canio J. ; et al.	2003-07-31
Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents App 20030124117 - Refino, Canio J. ; et al.	2003-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.